Functions, aberrations, and advances for chromatin modulation in cancer

Area of Science:

• Oncology
• Epigenetics
• Molecular Biology

Background:

• Cancer initiation and progression are linked to genome and epigenome deregulation.
• Epigenetic alterations, including DNA methylation, histone modifications, and miRNA modulation, are increasingly implicated in tumorigenesis.
• Various chromatin-modulating enzymes have been identified and their aberrations associated with cancer development.

Purpose of the Study:

• To explore the alterations occurring in chromatin enzymes.
• To understand the impact of these chromatin enzyme alterations in cancer.
• To highlight the importance of epigenetic targeting for cancer prevention and treatment.

Main Methods:

• Review of existing literature on epigenetic deregulation in cancer.
• Classification of chromatin-modulating enzymes.
• Analysis of the connection between enzyme aberrations and cancer pathology.

Main Results:

• Epigenetic deregulation is a significant factor in cancer initiation and progression.
• Specific chromatin-modulating enzymes and their aberrant functions are identified in various cancers.
• Understanding these alterations provides a basis for targeted epigenetic therapies.

Conclusions:

• Insights into chromatin enzyme alterations are crucial for advancing epigenetic cancer therapy.
• Targeting epigenetic mechanisms offers promising avenues for cancer prevention and treatment.
• Further research into chromatin enzyme functions in cancer is warranted.